Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results for the quarter and year ended 31.03.20262. Audit Report for the year ended 31.03.20263. Any other item with the permission of chair
Oxygenta Pharmaceutical Limited Press Release May 19 2026
Earlier from Oxygenta Pharmaceutical
- Oxygenta Pharmaceutical Limited Press Release Mar 25 2026
- Oxygenta Pharmaceutical Limited Press Release Feb 20 2026
